Impacts of Pre-Existing Antibodies on Transduction Efficiency of Systemic AAV9 Gene Delivery: Potential for Broader Patient Eligibility for AAV Gene Therapy

被引：0
|
作者：
Meadows, Aaron S. [1 ]
Pineda, Ricardo [1 ]
Fu, Haiyan [1 ]
机构：
[1] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA
来源：
MOLECULAR THERAPY | 2018年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
216
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [1] Transient depletion of pre-existing antibodies for efficient AAV gene delivery
    Fu, Haiyan
    Samowitz, Preston
    Forsberg, John
    Feng, Richard
    Nicely, Nathan
    Bobo, Tierra
    [J]. MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S44 - S44
  • [2] Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
    Saraiva, Joana
    Nobre, Rui Jorge
    de Almeida, Luis Pereira
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 241 : 94 - 109
  • [3] Strategy to detect pre-existing immunity to AAV gene therapy
    Falese, L.
    Sandza, K.
    Yates, B.
    Triffault, S.
    Gangar, S.
    Long, B.
    Tsuruda, L.
    Carter, B.
    Vettermann, C.
    Zoog, S. J.
    Fong, S.
    [J]. GENE THERAPY, 2017, 24 (12) : 768 - 778
  • [4] Strategy to detect pre-existing immunity to AAV gene therapy
    L Falese
    K Sandza
    B Yates
    S Triffault
    S Gangar
    B Long
    L Tsuruda
    B Carter
    C Vettermann
    S J Zoog
    S Fong
    [J]. Gene Therapy, 2017, 24 : 768 - 778
  • [5] Systemic AAV9 Gene Therapy of Spinal Muscular Atrophy
    Barkats, M.
    Benkhelifa-Ziyyat, S.
    Marais, T.
    Dominguez, E.
    Duque, S.
    Roda, M.
    Astord, S.
    Carcenac, R.
    Voit, T.
    [J]. HUMAN GENE THERAPY, 2011, 22 (10) : A16 - A17
  • [6] Pre-existing Anti-Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
    Jeune, Vedell Louis
    Joergensen, Jakob A.
    Hajjar, Roger J.
    Weber, Thomas
    [J]. HUMAN GENE THERAPY METHODS, 2013, 24 (02) : 59 - U89
  • [7] Impact of Pre-Existing Immunogenicity to AAV on Vector Transduction By Bmn 270, an AAV5-Based Gene Therapy Treatment for Hemophilia A
    Long, Brian
    Sandza, Krystal
    Holcomb, Jennifer
    Pherarolis, Juli
    Crockett, Lucy
    Falese, Lillian
    Hayes, Greg
    Arens, Jeremy
    O'Neill, Charles A.
    Pryer, Nancy
    Fonck, Carlos
    Zoog, Stephen
    Vettermann, Christian
    [J]. BLOOD, 2017, 130
  • [8] Transient Depletion of Pre-Existing Antibodies for Efficient AAV Gene Delivery Treating MPS IIIA in Mice
    Fu, Haiyan
    Samowitz, Preston
    Robinson, Michael
    Forsberg, John
    Feng, Richard
    Nicely, Nathan
    Bobo, Tierra
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 130 - 130
  • [9] Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
    Inagaki, Katsuya
    Fuess, Sally
    Storm, Theresa A.
    Gibson, Gregory A.
    Mctiernan, Charles F.
    Kay, Mark A.
    Nakai, Hiroyuki
    [J]. MOLECULAR THERAPY, 2006, 14 (01) : 45 - +
  • [10] Influence of Pre-Existing Neutralizing Antibodies on Gene Expression Following Intramuscular Administration of AAV Vectors
    Greig, Jenny A.
    McMenamin, Deirdre
    Wilson, James M.
    [J]. MOLECULAR THERAPY, 2011, 19 (07) : 1364 - 1365
12345